Specification
Iron stimulates erythropoiesis and increases resistance. After
parenteral administration, iron-(III)-dextran heptonic acid complex
slowly releases Fe+3 ions, which ensures the long-term effect of the
drug.
Nicotinamide (vitamin PP) stimulates NAD and NADP synthesis. In the
form of NAD and NADP, it participates in many redox reactions. Vitamin E is an active antioxidant. It inhibits lipid peroxidation,
prevents cellular structures from damage caused by free radicals. It
participates in tissue respiration, biosynthesis of heme and proteins,
carbohydrate and fat metabolism, cell proliferation and other
metabolic processes.
In the body, folic acid (vitamin B9
) is reduced to tetrahydrofolic acid,
which is a coenzyme in various metabolic processes. It has an effect
on normal megaloblastic maturation and normoblastic formation.
Folic acid also stimulates erythropoiesis and participates in the
synthesis of amino acids (including methionine and serine), nucleic
acids, purines and pyrimidines.
Cyanocobalamin (vitamin B12) is a water-soluble vitamin. It has
high biological activity, participates in a transmethylation reaction,
hydrogen transfer, formation of methionine, nucleic acids, choline,
creatine. Cyanocobalamin is necessary for normal hematopoiesis.
Vitamin B12 also promotes the accumulation of compounds
containing sulfhydryl groups in the erythrocytes, has a positive effect
on the function of the liver and nervous system, activates the blood
coagulation system. Cyanocobalamin administered at high doses
causes the increased activity of thromboplastin and prothrombin.
Indications
Ferraxx–forte® is used for treatment and prevention of irondeficiency anemia in piglets, calves, foals, lambs, goatlings and minks.
Composition
1 ml contains active substances:
• 20 mg of iron as iron-(III)-dextran heptonic acid complex;
• 20 mg of vitamin B3;
• 10 mg of vitamin E;
• 5 mg of vitamin B9;
• 0.1 mg of vitamin B12;
excipients: macrogol 15 hydroxystearate, benzyl alcohol and water for injection – up to 1 ml.
Dosage
Ferraxx–forte® is administered once:
• piglets (on 3 or 4 days of life): deep intramuscular injection to the neck region or upper thigh region at a dose of 0.75-1.0 ml per animal;
• calves and foals (in the first days of life): intramuscular injection to the thigh region at a dose of 2-4 ml per animal;
• lambs and goatlings (in the first days of life): intramuscular injection to the thigh region at a dose of 1.5-2.5 ml per animal;
• female minks (during lactation in spring): intramuscular or subcutaneous injection at a dose of 0.15 ml per animal;
• mink pups (at the age of 6-12 weeks): intramuscular or subcutaneous injection at a dose of 0.1 ml per animal.